Drug Profile
Filgrastim biosimilar - Sedico
Alternative Names: Filgrastim SEDICO; Recombinant human granulocyte-colony stimulating factor - SedicoLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Sedico
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 28 Feb 2014 Launched prior to February 2014 for Neutropenia in Egypt (IV)
- 28 Feb 2014 Launched prior to February 2014 for Neutropenia in Egypt (SC)